Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Michael Mussallem.

Executive Summary

During the annual J.P. Morgan Healthcare Conferences on 10 January, Edwards Lifesciences CEO Michael Mussallem affirmed previous revenue guidance and discussed plans for 2022.

“We expect [2022] to be a year of significant milestone achievements and a lot of investments in our future." – Michael Mussallem, CEO, Edwards Lifesciences

Click here for a free trial of Medtech Insight

 

Related Content

Topics

UsernamePublicRestriction

Register

MT144931

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel